Bluejay Diagnostics, Inc. (BJDX) earnings
BJDX earnings moved a median of +0.86% by the close. Quarterly and annual BJDX reports and results, each read against the price at its own news timestamp. Back to the BJDX overview →
16 measured BJDX earnings events.
Where these BJDX earnings landedvs 14 measured BJDX earnings reactions
| Middle 50% of BJDX earnings reactions | -3.46% to +4.91% |
|---|---|
| Median reaction (to close) | +0.86% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 BJDX earnings events with a measured close landed between -3.46% and +4.91%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update | Press release | — | — | |
| Form 10-Q Bluejay Diagnostics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization | Press release | +2.50% | +6.00% | |
| Form 10-Q Bluejay Diagnostics, For: Jun 30 | SEC filing · Form 10-Q | +2.50% | +6.00% | |
| Bluejay Diagnostics Provides First Quarter 2026 Corporate Update | Press release | +0.00% | -4.97% | |
| Form 10-Q Bluejay Diagnostics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.97% | |
| Form 10-K Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | +0.54% | +1.08% | |
| Form 10-Q Bluejay Diagnostics, For: Sep 30 | SEC filing · Form 10-Q | +1.11% | +0.64% | |
| Form 10-Q Bluejay Diagnostics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.11% | |
| Form 10-Q Bluejay Diagnostics, For: Mar 31 | SEC filing · Form 10-Q | +1.15% | -1.72% | |
| Form 10-K/A Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | +3.85% | +4.95% | |
| Form 10-K Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | +0.54% | -2.95% | |
| Form 10-Q Bluejay Diagnostics, For: Sep 30 | SEC filing · Form 10-Q | +4.51% | +13.75% | |
| Form 10-Q Bluejay Diagnostics, For: Jun 30 | SEC filing · Form 10-Q | +4.32% | +4.79% | |
| Form 10-Q Bluejay Diagnostics, For: Mar 31 | SEC filing · Form 10-Q | -6.21% | +2.92% | |
| Form 10-K Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | -1.63% | -3.63% |
Keep exploring
More BJDX: analyst actions → · SEC filings → · BJDX overview →